At close: 3:53:19 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
7,001.9340
7,001.9340
16,595.0530
15,207.6810
20,214.0650
Operating Income
-7,001.9340
-7,001.9340
-16,595.0530
-15,207.6810
-20,214.0650
Net Non Operating Interest Income Expense
-24.2300
-24.2300
41.5140
-30.3910
-2,046.7490
Other Income Expense
3,448.0470
3,448.0470
1,497.1660
-3,428.7380
12,914.0650
Pretax Income
-3,578.1170
-3,578.1170
-15,056.3730
-18,666.8100
-9,346.7490
Net Income Common Stockholders
-3,578.1170
-3,578.1170
-15,056.3730
-18,666.8100
-9,346.7490
Basic EPS
-0.01
-0.01
-0.05
-0.06
-0.04
Diluted EPS
-0.01
-0.01
-0.05
-0.06
-0.04
Basic Average Shares
292,237.9500
292,237.9500
292,237.9500
291,221.7270
263,850.6890
Diluted Average Shares
292,237.9500
292,237.9500
292,237.9500
291,221.7270
263,850.6890
Net Income from Continuing & Discontinued Operation
-3,578.1170
-3,578.1170
-15,056.3730
-18,666.8100
-9,346.7490
Normalized Income
-3,578.1170
-3,578.1170
-14,996.4340
-18,666.8100
-9,346.7490
Interest Income
6.9300
6.9300
82.5090
46.9440
139.4720
Interest Expense
31.1600
31.1600
40.9950
77.3350
2,186.2210
Net Interest Income
-24.2300
-24.2300
41.5140
-30.3910
-2,046.7490
EBIT
-3,546.9570
-3,546.9570
-15,015.3780
-18,589.4750
-7,160.5280
EBITDA
-3,545.2140
-3,545.2140
-14,860.8440
-18,327.9620
-6,898.8050
Reconciled Depreciation
1.7430
1.7430
154.5340
261.5130
261.7230
Net Income from Continuing Operation Net Minority Interest
-3,578.1170
-3,578.1170
-15,056.3730
-18,666.8100
-9,346.7490
Total Unusual Items Excluding Goodwill
--
--
-59.9390
--
--
Total Unusual Items
--
--
-59.9390
--
--
Normalized EBITDA
-3,545.2140
-3,545.2140
-14,800.9050
-18,327.9620
-6,898.8050
6/30/2021 - 8/9/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NYR.AX Nyrada Inc.
0.1050
-4.55%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0370
0.00%
NUZ.AX Neurizon Therapeutics Limited
0.1850
+5.71%
MEM.AX Memphasys Limited
0.0060
+20.00%
MDC.AX Medlab Clinical Limited
6.60
0.00%
RNV.AX RENERVE FPO [RNV]
0.1450
-14.71%
AVE.AX Avecho Biotechnology Limited
0.0030
0.00%
PIQ.AX Proteomics International Laboratories Ltd
0.6800
+7.94%
SPL.AX Starpharma Holdings Limited
0.1150
0.00%
OPT.AX Opthea Limited
0.6450
-3.73%